Percival Bazeley production of an important new weapon against disease. Twenty-five million doses of Salk Poliomyelitis vaccine were produced at CSL in the 1950s and 1960s under Dr. Bazeley's leadership as director of the government institution. This led to widespread recognition. He was awarded a C.B.E. (Commander of the Order of the British Empire) and was deservedly renowned in the general community where, for example, he was chosen as Victorian Father of the Year in 1958. In 1961, Dr. Bazeley returned to the United States to work with Jonas Salk at the Salk Institute in La Jolla, California. Subsequently, he joined UC
SAV001 a feasible option for an HIV vaccine. Indeed, Jonas Salk developed a therapeutic HIV vaccine in 1987, called Remune now being developed by Immune Response BioPharma, Inc., is based on the killed whole virus approach. Remune vaccine has completed over 25 clinical studies to date and showed a robust mechanism of action restoring white blood cell counts in CD4 & CD8 T cells by reducing viral load and increasing immunity. Also, a group of researchers and professionals in the field of HIV strongly advocates that the killed HIV approach must be taken to fight back the global HIV and AIDS